LATYPOVA, G.M.,
BYCHENKOVA, M.A.,
KATAYEV, V.A.,
PERFILOVA, V.N.,
TYURENKOV, I.N.,
MOKROUSOV, I.S.,
PROKOFIEV, I.I.,
SALIKHOV, SH.M.,
IKSANOVA, G.R. (2019) , we used the model of CHF to elucidate the cardioprotective properties of PVSHE.
Methods. The
active: on the one hand, the formation of legal awareness must base on the
level of existing knowledge and the target
LIU, Z.,
ZHANG, R.,
CHEN, X.,
YAO, P.,
YAN, T.,
LIU, W.,
YAO, J.,
ZHAO, S.,
SOKHATSKII, A.,
GAREEV, I. (2019) -molecule compounds with potential therapeutic effects. Finally, we verified the expression
levels of the hub genes